RMD:NYSE
Resmed Inc
230,05 USD
arrow_upward
+1,46%(+3,32) 1D
230,05 USD
0,00% (0,00)
bedtimeNakon radnog vremena
Zatvoreno: 9. lis, 16:00:04 GMT -4 · USD
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za RMD...
Otvori
226,54 USD
Najviša
231,36 USD
Najniža
226,42 USD
Trž. kap.
32,35 mlr.
Prosj. kol.
1,22 mil.
Količina
1,00 mil.
Dividenda
1,15 %
Kvartalna dividenda
0,66 USD
Datum nakon isplate dividende
20. kol 2026.
P/E omjer
22,06
52-tjed. najviša
277,85 USD
52-tjed. najniža
180,26 USD
EPS
10,43 USD
Beta
0,75
Dionice u optjecaju
140,64 mil.
Broj djelatnika
11 tis.
Otvori
226,54 USD
Najviša
231,36 USD
Najniža
226,42 USD
Trž. kap.
32,35 mlr.
Prosj. kol.
1,22 mil.
Količina
1,00 mil.
Dividenda
1,15 %
Kvartalna dividenda
0,66 USD
Datum nakon isplate dividende
20. kol 2026.
P/E omjer
22,06
52-tjed. najviša
277,85 USD
52-tjed. najniža
180,26 USD
EPS
10,43 USD
Beta
0,75
Dionice u optjecaju
140,64 mil.
Broj djelatnika
11 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
TipRanks
·
prije 23 sata
ResMed CEO Farrell Exercises Options and Sells Shares Under 10b5-1 Plan
Kalkine
·
prije 23 sata
ResMed Chairman and CEO Michael Farrell Sells 4,991 Shares on 7 October 2026
MarketBeat
·
prije 1 dan
ResMed (NYSE:RMD) Stock: Insider Michael Farrell Sells 4,991 Shares
Investing.com
·
prije 1 dan
ResMed chairman & CEO Michael Farrell sells $1.1m in shares
Profil
Resmed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers.
Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024. Wikipedia
Resmed Inc – informacije
Glavni izvršni direktorMichael J. Farrell
Zaposlenici11,4 tis.
Osnovanolip 1989
SjedišteSan Diego, Kalifornija, Sjedinjene Američke Države
Sektor-
Web-lokacijaresmed.com